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AlthoughMycobacterium abscessus (M. abscessus) is becoming more prevalent in patients without overt immunodeficiency,
little is known about the factors that contribute to disease susceptibility. This study was undertaken to investigate how Toll-like
receptor 2 (TLR2) functionally contributes to the generation of protective immunity againstM. abscessus in a morphotype-spe-
cific manner. We found that Tlr2/mice were extremely susceptible to an intravenous (i.v.) model of infection byM. abscessus
rough variants, displaying uncontrolled infection in the lungs and a significantly lower survival rate than with wild-type (WT)
mice. This uncontrolled infection resulted from failures in the following processes: (i) production of the crucial cytokines
gamma interferon (IFN-), tumor necrosis factor alpha (TNF-), and interleukin 12p70 (IL-12p70); (ii) early infiltration of
neutrophils, monocytes, and dendritic cells (DCs) in the lungs of Tlr2/mice; (iii) rapid influx of CD4 and CD8 T cells; and
(iv) the expansion of memory/effector T cells. Notably, systemic administration ofM. abscessus culture filtrate-treated syngeneic
DCs fromWTmice greatly strengthened immune priming in vivo, resulting in a dramatic reduction in bacterial growth and im-
proved long-term survival in Tlr2/mice, with a recovery of protective immunity. Our findings demonstrate that TLR2 is an
essential contributor to instructive and effector immunity duringM. abscessus infection in a morphotype-specific manner.
Mycobacterium abscessus (sensu stricto) is an emerging rapidlygrowing mycobacterium (RGM) that causes a wide spec-
trumof infections in humans, including lung, skin, soft tissue, and
bone diseases (1). M. abscessus is the most drug-resistant myco-
bacterial pathogen, resulting in limited therapeutic options and a
high rate of treatment failure (2).
Interestingly, the outcomes of mycobacterial infections can
range from asymptomatic clearance to severe clinical disease (3).
Different pathogen- and host-specific factors have been consid-
ered in determining the outcomes of these infections. However, it
is clear that the interaction between mycobacteria and the innate
and adaptive immune systems plays a central role in host defense
and pathogenesis (3). In fact, the recognition of mycobacterial
components by innate immune cells through various pattern rec-
ognition receptors (PRRs) induces a cytokine response that can
promote early control of the infection (3, 4).
Toll-like receptor (TLR)-mediated immune activation occurs
only in the presence of functional TLRs, and TLR variants may
exhibit altered expression, function, and recognition of signaling
mechanisms, thereby increasing disease susceptibility. Healthy in-
dividualswhodevelop nontuberculousmycobacterial (NTM)dis-
eases, including those caused by M. abscessus, likely have specific
susceptibility factors that make them vulnerable to these infec-
tions (5). Previous studies have demonstrated an association be-
tween human TLR2 polymorphisms and tuberculosis or Myco-
bacterium avium complex (MAC) lung disease (6–8). In addition,
TLR1 is required for TLR2 signaling, and the TLR1 single nucle-
otide polymorphism (SNP) I602S has been found in a cystic fibro-
sis cell line, resulting in a lack of recognition ofM. abscessus rough
variants by TLR2.
Furthermore, an age-associated decrease in TLR function has
been identified (9). The rate of M. abscessus infection has in-
creased, predominantly in older women (5). Thus, delineating the
molecular recognition pattern of M. abscessus is important for
understanding how host resistance is induced, maintained, and
regulated during infection. To date, a limited number of in vivo
studies have investigated the roles of innate immunity and adap-
tive immunity in M. abscessus infections (10–13).
Based on colony morphology on solid growth medium, there
are two major variants ofM. abscessus: the smooth (S) and rough
(R) morphotypes (12). The cell walls of the S variant ofM. absces-
sus are enriched with glycopeptidolipids (GPLs), and this variant
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is thought to be the predominant morphotype in the environ-
ment; however, the R variant is more likely to cause invasive dis-
ease and is considered more pathogenic because of its association
with excessive inflammation uponTLR2 ligation (14–16). Despite
extensive research, no conclusive evidence of a link between in-
nate and adaptive immunity to M. abscessus infections in a mor-
photype-dependentmanner has been produced, especially in vivo.
Therefore, an understanding ofmolecular immunity toM. absces-
sus infection is critical for the development of effective strategies
to treat M. abscessus infection.
In the current study, we have found that TLR2 is essential for
efficient control of hypervirulent M. abscessus R variant infection
in mice and serves as an intermediary between the innate and
adaptive immune responses. We also investigated the importance
of dendritic cell (DC) activation through TLR2 signaling in the
generation of early protective immunity, and we attempted DC
therapy for M. abscessus infection for the first time.
MATERIALS AND METHODS
Bacterial strains, cultures, and preparation of single-cell suspensions.
The type strainM. abscessus ATCC 19977T was obtained from the Amer-
ican Type Culture Collection (ATCC, Manassas, VA, USA). All strains
were initially cultured in 7H9 broth (Difco Laboratories, Detroit, MI,
USA) supplemented with 10% (vol/vol) oleic acid-albumin-dextrose-cat-
alase (OADC; BectonDickinson, Sparks,MD,USA) for 7 days at 37°C.M.
abscessus ATCC 19977T originally showed a smooth morphotype (M. ab-
scessus S), and an isogenic rough variant (M.abscessusR)was isolated from
the lungs of C57BL/6J mice infected with the smooth morphotype of M.
abscessus ATCC 19977T during macrolide treatment. The smooth and
rough isogenic strains of M. abscessus ATCC 19977T were confirmed to
have identical genotypes by variable-number tandem repeat (VNTR)
analysis (17).
The morphotypes of these strains were stably maintained in in vitro
culture for more than 20 passages. Additionally, infection experiments
in mice using both variants resulted in no changes in the colony mor-
phologies of the S and R variants ofM. abscessus recovered from the lung.
Single-cell suspensions of each strain were prepared as described previ-
ously, with slightmodifications (16). Briefly, mycobacterial cells grown in
OADC-supplemented 7H9 broth were harvested by centrifugation at
10,000  g for 20 min and washed three times in 10 mM phosphate-
buffered saline (PBS; pH 7.2). The pellets were homogenized using an
overhead stirrer (Wheaton Instrument, Millville, NJ, USA) for 1 min on
ice to minimize clumping of bacteria. The homogenized mycobacterial
cells were passed through an 8-m-pore-size filter (Millipore Corp., Bed-
ford, MA, USA). The seed lots of each strain were then kept in small
aliquots at80°C until use. The number of CFU per 1 ml of the seed lots
was measured by a viable counting assay on 7H10 agar plates.
Ethics statement. All animal experiments were performed in accor-
dance with the guidelines of the Korean Food and Drug Administration
(KFDA). The experimental protocols used in this studywere reviewed and
approved by the Ethics Committee and Institutional Animal Care andUse
Committee (permit number 2012-010) of the Laboratory Animal Re-
search Center at Yonsei University College of Medicine (Seoul, South
Korea).
Animals and infection.Wild-type (WT),Tlr2/,Tlr4/, OT-I, and
OT-II T-cell receptor (TCR) transgenicmice (C57BL/6 background)were
purchased from the Jackson Laboratory (Bar Harbor, ME). The animals
were fed a sterile commercial mouse diet andwere provided with water ad
libitum. The in vivo virulence levels of the rough and smoothmorphotype
strains of M. abscessus were compared based on the survival rates of the
mice and the numbers of bacterial CFU in the lungs in the initial animal
infection study. Briefly, 6- to 7-week-old C57BL/6J, Tlr2/, and Tlr4/
mice were intravenously (i.v.) infected with low (1.4 107 CFU/mouse)
or high (2.0 107 CFU/mouse) doses of M. abscessus R or S via tail vein
injection. Some mice were intranasally (i.n.) infected with 9 106 CFU/
mouse ofM. abscessus R. At each postinfection time point, the mice were
euthanized by CO2 inhalation, and the lungs, livers, and spleens were
aseptically collected for bacterial counts or immune cell analysis. The
numbers of viable bacteria in the organs were determined by plating serial
dilutions of organ homogenates onto 7H10-OADC agar plates. Colonies
were counted after 5 days of incubation at 37°C. Differences between the
groups are presented as the mean log10 CFU counts standard errors of
the means (SEM) per group.
Histology.Tissue samples collected for histopathologywere preserved
in 10% neutral buffered formalin, embedded in paraffin, cut into 2- to
3-m sections, and stained with hematoxylin and eosin or acid-fast stain,
as described previously (18, 19). Two independent pathologists per-
formed blinded examinations of tissue sections from infected animals at 7
and 14 days postinfection. Each section was scored as absent (0), mild (1),
moderate (2), severe (3), or extremely severe (4). The severity of the in-
flammatory response was scored on a scale of 0 to 4 based on lesion size
and the number of lesions per field. Tissues with multiple large lesions in
more than three fields were assigned a score of 4.
Antibodies and reagents. Recombinant mouse granulocyte-macro-
phage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) were
purchased from R&D Systems (Minneapolis, MN). The following anti-
bodieswere purchase fromeBioscience (SanDiego, CA,USA): fluorescein
isothiocyanate (FITC)-conjugated monoclonal antibody (MAb) for
CD11b and CD62L; allophycocyanin (APC)-conjugated MAb for F4/80
and CD11c; eFluor450-conjugated MAb for CD3; peridinin chlorophyll
protein (PerCP)-Cy5.5-conjugated MAb for CD4 and CD8; phyco-
erythrin (PE)-conjugated MAb for Gr-1, CD80, CD86, major histocom-
patibility complex class I (MHC-I), MHC-II, and CD44; PE-Cy5-conju-
gated MAb for CD4 and CD8; and PE-Cy7-conjugated MAb for
CD11c.
Cytokine measurement. The levels of gamma interferon (IFN-), tu-
mor necrosis factor alpha (TNF-), IL-1	, IL-10, and IL-12p70 were de-
termined by enzyme-linked immunosorbent assay (ELISA) in bronchoal-
veolar lavage (BAL) fluid and serum collected at 2, 5, 7 and 14 days
postinfection, according to the manufacturer’s instructions (eBio-
science). BAL fluid samples were harvested by infusing 1 ml of ice-cold
PBS through a 25-gauge blunt needle into the lungs via the trachea, fol-
lowed by gentle aspiration of this fluid into a syringe at 2, 5, 7, and 14 days
postinfection (20). BAL fluid and cells were separated by centrifugation at
13,000 g for 10min at 4°C. The supernatants were carefully collected for
ELISA, and the cell pellets were collected for flow cytometry.
Flow cytometry. Cells were washed in ice-cold flow cytometry buffer
(2%, vol/vol, bovine serum albumin and 2 mM EDTA in PBS, pH 7.5),
incubated with each antibody for 15 min, and washed twice with flow
cytometry buffer. Data were acquired on a FACSCanto II flow cytometer
(BDBiosciences, SanDiego, CA,USA) and analyzedwith FlowJo software
(Tree Star, Inc., Ashland, OR, USA).
Preparation of CFAs. Culture filtrate antigens (CFAs) were prepared
from cultures at the mid-log phase of growth after 2 weeks of incubation
at 37°C, as described previously (21). Briefly, cells grown in modified
Watson-Reidmedium (mWR; pH 6.0) were removed by centrifugation at
30,000  g for 30 min. After filtration through a 0.2-m-pore-size filter
(Millipore), the filtrate was concentrated 40- to 50-fold using a Centricon
Plus-80 filter unit (5-kDa-molecular-weight cutoff; Amicon, Beverly,
MA, USA) and dialyzed five times in 10 mM PBS using a Slide-A-Lyzer
dialysis cassette (Pierce, Rockford, IL, USA).
Generation and culture of DCs. Immature mouse bone marrow-de-
rivedDCs (BM-DCs)were generated as described previously (22). Briefly,
whole bone marrow cells isolated from C57BL/6, Tlr2/, and Tlr4/
mice were washed with serum-free RPMI 1640 medium. The cells were
plated in petri dishes and cultured at 37°C in the presence of 5% CO2
using RPMI 1640 medium supplemented with 100 units/ml penicillin-
streptomycin (Lonza, Basel, Switzerland), 10% fetal bovine serum
(Lonza, Basel, Switzerland), 50 M mercaptoethanol (Lonza), 20 ng/ml
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GM-CSF, and 5 ng/ml IL-4. On day 6, over 80% of the nonadherent cells
expressed CD11c. To obtain highly purified populations for subsequent
analyses, the DCs were labeled with bead-conjugated anti-CD11c MAb
(Miltenyi Biotec, Bergisch Gladbach, Germany), followed by positive se-
lection on paramagnetic columns (LS columns; Miltenyi Biotec) accord-
ing to the manufacturer’s instructions. The purity of the cell fraction
selected was
95%.
Mixed lymphocyte reaction (MLR). Responder T cells, which partic-
ipate in allogeneic T-cell reactions, were isolated using a magnetic cell
sorting (MACS) column (Miltenyi Biotec) from total mononuclear cells
prepared from BALB/c mice. Ovalbumin (OVA)-specific CD8 and
CD4 T cells (responders) were obtained from splenocytes of OT-1 and
OT-2 mice, respectively. These T cells were stained with 1 M carboxy-
fluorescein diacetate succinimidyl ester (CFSE; Invitrogen, Carlsbad, CA,
USA) as previously described (22). DCs treated with OVA peptide in the
presence of 10 g/ml M. abscessus CFA for 24 h were cocultured with
CFSE-stainedCD8 andCD4T cells at aDC/T-cell ratio of 1:10. On day
2 or 3 of coculture, the T cells were stained with PerCP-Cy5.5-conjugated
anti-CD4 MAb, PE-Cy5-conjugated anti-CD4 MAb, and PE-Cy5-
conjugated anti-CD8MAb prior to analysis by flow cytometry. The su-
pernatants were harvested and evaluated to determine the production of
IFN-, IL-2, and IL-4 by ELISA.
DC immunotherapy. Mice were infected i.v. with M. abscessus R
(1.0  107 CFU/mouse) prior to the injection of immature DCs and M.
abscessus CFA-treated BM-DCs (1.0 106) via the tail vein on postinfec-
tion day 2. At each postinfection time point, the mice were euthanized by
CO2 inhalation, and their lungs were aseptically collected for bacterial
counts and histopathological analysis. The numbers of viable bacteria in
the lungs were determined as described above. Each experiment was car-
ried out twice.
Statistical analysis. All experiments were repeated at least three times
with consistent results. Significant differences between samples were de-
termined with Tukey’s multiple-comparison tests using statistical soft-
ware (GraphPad Prism software, version 4.03; GraphPad Software, San
Diego, CA, USA). The data in the graphs are expressed as the means 
SEM, and P values of 0.05, 0.01, and 0.001 were considered statis-
tically significant. Survival curveswere analyzed using aKaplan-Meyer log
rank test.
RESULTS
TLR2-deficientmice are extremely susceptible to infectionwith
M. abscessusR. To investigate the importance of TLR2 in the host
defense againstM. abscessus strains, we infected Tlr2/, Tlr4/,
andWTmice i.v. with a low (1.4 107 CFU/mouse) or high (2
107 CFU/mouse) dose of isogenicM. abscessusR orM. abscessus S.
We then examined survival rates and bacterial CFU counts in the
lungs. Themajority of theWT and Tlr4/mice infected with the
low dose of M. abscessus R survived until day 25; however, mice
lacking TLR2 had a significantly lower survival rate than WT and
Tlr4/mice. All deaths occurred within 21 days of infection (Fig.
1A). In contrast, there was no significant difference in mortality
rates among the three mouse strains infected with the low dose of
M. abscessus S; all mice survived until day 15 (see Fig. S1A in the
supplemental material). When the mice were infected with a high
dose ofM. abscessus R, WT and Tlr4/mice died within 12 days
postinfection. Interestingly, all Tlr2/ mice died within 5 days
postinfection (Fig. 1B). We further assessed the growth of M. ab-
scessus in the lungs, spleen, and liver after bacterial infection.
When themice were infected with a low dose of bacteria, bacterial
loads in the lungs were slightly elevated at 7 days postinfection in
all mouse strains, with no significant difference among the strains
(Fig. 1C). The levels of bacteria in the lungs of WT and Tlr4/
mice slowly decreased beginning at 7 days postinfection. In con-
trast, the bacteria in the lungs of Tlr2/ mice grew in an unre-
stricted manner until 19 days postinfection (Fig. 1C). Similar re-
sults were obtained with the high-dose M. abscessus R infection
(Fig. 1D). The numbers of bacteria in the spleen and liver of WT
and Tlr4/ mice decreased continuously by 19 days postinfec-
tion; however, bacterial numbers in the spleen and liver ofTlr2/
mice increased or did not change (see Fig. S2A and B in the sup-
plementalmaterial). In contrast, bacterial CFUcounts in the lungs
decreased continuously in mice infected with a high dose of M.
abscessus S, and the mice survived until the end of the experiment
(see Fig. S1A and B). Histopathological analysis revealed well-
defined granulomatous lesions in WT mice in the early stages of
infection (day 7). In comparison, no definitive granuloma was
observed in the lungs of Tlr2/mice. As the infection progressed
in WT mice, the granulomatous lesions disappeared. In contrast,
lesions with multifocal infiltration of most types of immune cells
were found in the lungs of Tlr2/mice (Fig. 1E). The inflamma-
tion score reached 3 to 3.5 in the lungs of WT mice at 7 days
postinfection. This score was significantly higher than that in
Tlr2/ mice. However, at 14 days postinfection, the inflamma-
tion score in the lungs was higher in Tlr2/ mice than in WT
mice (Fig. 1F).
To further investigate the importance of TLR2 in the relation-
ship between the route of infection and susceptibility toM. absces-
sus, we challenged WT and Tlr2/mice i.n. with M. abscessus R
and examined bacterial CFU counts and histological changes in
the lungs over 20 days. At 10 days postinfection, bacterial loads in
the lungs were significantly increased in Tlr2/ mice compared
with levels in WT mice (see Fig. S3A and B in the supplemental
material). While WT mice eliminated M. abscessus R efficiently
until 20 days postinfection, Tlr2/mice failed to do so (see Fig.
S3A). Histopathological analysis revealed that most Tlr2/mice
displayed a multifocal-to-coalescing well-delineated inflamma-
tory lesion centered on the bronchioles and secondarily extending
to the alveoli, leading to a complete loss of alveolar spaces. The
alveolar spaceswere filled by various immune cells, including lym-
phocytes, neutrophils, and macrophages, until 20 days postinfec-
tion. In contrast,WTmice displayed focal inflammatory lesions at
10 days postinfection, most of which had disappeared at 20 days
(see Fig. S3C). As shown in Fig. S3D in the supplemental material,
the inflammation score reached 2 to 2.5 in the lungs of Tlr2/
mice at 10 and 20 days postinfection, which was significantly
higher than that in the lungs of WT mice (score of 0 to 0.5).
Accordingly, we concluded that TLR2 is crucial for protection
against M. abscessus R and that Tlr2/ mice are extremely sus-
ceptible to i.v. infection by M. abscessus R.
TLR2participates inmacrophage activation but not in intra-
cellular control ofM. abscessus. Although the above results indi-
cated that TLR2 is a key factor for the regulation ofM. abscessus R
inmice, we could not exclude the possibility that TLR2 has a direct
effect on the ability to control bacterial growth or cytokine pro-
duction in the infected macrophages. To test this hypothesis, we
infectedWT, Tlr2/, and Tlr4/ bone marrow-derived macro-
phages (BMDMs) with M. abscessus S and M. abscessus R and
measured intracellular growth for 72 h. The intracellular growth
of S and R variants in Tlr2/ BMDMs was similar to that in WT
and Tlr4/ cells (see Fig. S4A and B in the supplemental mate-
rial); however, the production of TNF- and IL-10 by Tlr2/
BMDMs infected with R variants was significantly (P  0.001)
lower than that in WT and Tlr4/ BMDMs. In contrast, no dif-
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ference in the production of these cytokines was observed in cells
infected with M. abscessus S (see Fig. S4C and D).
TLR2 is involved in cytokine production in the bronchoal-
veolar lavage fluid of mice infected with M. abscessus R. To in-
vestigate whether TLR2 is involved in the production of inflam-
matory cytokines following infection with R variants, BAL fluid
was obtained from infectedmice at each time point, and the levels
of IFN-, TNF-, IL-12p70, and IL-10 in the BAL fluid weremea-
sured by ELISA. The production of proinflammatory cytokines
such as IFN-, TNF-, and IL-12p70 in the BAL fluid of WT and
Tlr4/ mice increased significantly by 7 days postinfection and
decreased to baseline levels after 14 days; however, significant
changes in the levels of these cytokineswere not observed until day
14 in Tlr2/mice (Fig. 2A). The production of the anti-inflam-
matory cytokine IL-10 gradually increased, but there was no sig-
nificant difference in the BAL fluid of WT and Tlr4/mice until
14 days postinfection. In contrast, Tlr2/mice displayed a rapid
and significant increase in IL-10 levels between day 7 and day 14
postinfection (Fig. 2A).
We further investigated whether TLR2 is involved in the pro-
duction of inflammatory cytokines in serum followingM. absces-
sus R infection. Serum was collected from infected mice at each
time point, and the levels of IFN-, TNF-, IL-12p70, and IL-10
were measured by ELISA. The production of IFN-, TNF-, and
IL-12p70 in the serum of WT and Tlr4/ mice increased by 2
days postinfection and returned almost to baseline after 7 days. In
contrast, an increase in these cytokines was not observed until 14
days in Tlr2/ mice (see Fig. S5A to C in the supplemental ma-
terial). IL-10 gradually increased in the serum of all experimental
groups until 14 days postinfection (see Fig. S5D). These results
indicate that high levels of proinflammatory cytokine production
may play an important role in the control of M. abscessus R vari-
ants in the early stages of infection and that TLR2 regulates the
production of these cytokines.
TLR2deficiency leads todecreased recruitmentof inflamma-
tory cells to the bronchoalveolar space inmice infected withM.
abscessusR.Toquantify inflammatory cell recruitment, BALfluid
was collected from WT, Tlr2/, and Tlr4/ mice at 7 and 14
FIG 1 Tlr2/mice are highly susceptible to i.v. infection withM. abscessus R.WT, Tlr2/, and Tlr4/mice were infected i.v. with 1.4 107 (A) or 2.0 107
(B) M. abscessus R CFU/mouse (n  30 animals per group), and survival was monitored for the indicated number of days after infection. The results shown
represent three independent experiments. (C andD) Three groups of mice were infected i.v. with 1.4 107 (C) or 2.0 107 (D)M. abscessusRCFU/mouse. The
lungs were harvested at the indicated time points, andmycobacterial loads were determined using a standard plate countmethod. The results are expressed as the
mean estimated number of CFU SEM from the lung samples of five to six mice in three independent experiments. Statistically significant differences in CFU
are shown for Tlr2/ compared with WTmice (**, P 0.01; ***, P 0.001). (E) Histopathology of lungs fromWT and Tlr2/mice infected i.v. with 1.4
107M. abscessusRCFU. Lung sections were stained with hematoxylin and eosin (magnification,4). (F) Inflammatory scores of hematoxylin and eosin-stained
lung sections. The graph denotes the average inflammatory score observed in the lungs following infection with 1.4 107 CFU/mouse (five mice per group per
time point). Each section was blindly evaluated and scored as absent (0), mild (1), moderate (2), severe (3), or extremely severe (4). Scale bar, 1 mm.
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days after i.v. infectionwithM. abscessusR, andBAL cells retrieved
from the BAL fluid were stained and counted to determine the
types of cells recruited into the bronchoalveolar space. As shown
in Fig. 2B to F, recruitment of F4/80CD11bmid CD11cmidmono-
cytes, F4/80 CD11bhigh CD11chigh DCs, F4/80 CD11bmid
CD11chigh DCs, F4/80 CD11bhigh CD11clow macrophages, and
F4/80 CD11c CD11b Gr-1 neutrophils (where low, inter-
mediate [mid], and high levels of expression are indicated by su-
perscripts) into the bronchoalveolar space was markedly reduced
in Tlr2/ mice compared with WT and Tlr4/ mice at 7 days
postinfection. Interestingly, recruitment of all inflammatory cells
in the bronchoalveolar space was significantly reduced inWT and
Tlr4/mice at 14 days postinfection, while recruitment of those
cells was increased in Tlr2/ mice. The recruitment of CD3
FIG 2 Cytokine production and cellular influx into the bronchoalveolar lavage fluid. WT, Tlr2/, and Tlr4/ mice were infected i.v. with 1.4  107 M.
abscessus R CFU/mouse. (A) BAL fluid was harvested at the indicated time points, and the levels of IFN-, TNF-, IL-12p70, and IL-10 were determined by
ELISA. (B) Immune cells were assayed by flow cytometry on days 7 and 14 postinfection. A representative dot blot was primarily gated on FSCmid/high/SSCmid/high
(where FSC is forward scatter and SSC is side scatter) and secondarily gated on F4/80low. F4/80low CD11bmid CD11cmid cells were classified as monocytes and
F4/80low CD11bhigh CD11chigh cells were classified as CD11bhigh dendritic cells. F4/80low CD11blow CD11chigh cells were classified as CD11blow dendritic cells. (C)
A representative dot blot was primarily gated on FSCmid/high/SSCmid/high and secondarily gated on F4/80high. F4/80high CD11bhigh CD11clow/mid cells were
classified as CD11bhighmacrophages, and F4/80low CD11blow CD11chigh cells were classified as alveolarmacrophages. (D) A representative dot blot was primarily
gated on FSCmid/high/SSCmid/high and secondarily gated on CD11clow F4/80low. F4/80low CD11clow CD11Bhigh Gr-1high cells were classified as neutrophils. (E)
CD4 and CD8 T-cell influx into the lungs. A representative dot blot of bronchoalveolar lavage cells was primarily gated on FSCmid/SSClow and secondarily
gated on CD3high. Numbers indicate the percentages of cells in each quadrant. (F) The bar graph represents the absolute number of cells in each quadrant or
square on days 7 and 14 after the initial infection. The results are presented as the means SEM of each group (*, P 0.05; **, P 0.01; ***, P 0.001).
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CD4 and CD3 CD8 T cells in the bronchoalveolar space in-
creased continuously from 7 to 14 days in WT and Tlr4/mice.
In contrast, recruitment of these cells was not observed until 14
days in Tlr2/ mice (Fig. 2E and F). These results indicate that
TLR2 is essential for the recruitment of immune cells and the
initiation of adaptive immunity against M. abscessus R.
TLR2 deficiency leads to decreased T-cell activation and
IFN- production during M. abscessus R infection. TLR2 was
found to play a major role in the secretion of cytokines and the
recruitment of various immune cells in mice infected with M.
abscessus R. The role of TLR2 was determined by analyzing the
expansion of and phenotypic changes in splenic T cells. The num-
bers of CD4 and CD8 cells were significantly increased in the
spleens of WT and TLR4/ mice at 7 days, whereas these num-
bers were decreased by 14 days. In contrast, the percentages of
CD4 andCD8 cells were not increased inTlr2/mice at 7 days
postinfection but were elevated at 14 days postinfection (Fig. 3A).
These findings indicate that TLR2 is critical for inducing early-
stage adaptive immunity. Similarly, the spleens of WT and
Tlr4/ mice were greatly enlarged at day 7 compared with the
spleens of Tlr2/ mice, which resembled those of uninfected
mice (Fig. 3B). Changes in naive and effector/memory T cells were
FIG 3 Comparative flow cytometric analysis of T-cell populations from the spleens of WT, Tlr4/, and Tlr2/mice following infection withM. abscessus R.
(A) Total numbers of CD4 andCD8 cells in the spleens ofWT,Tlr2/, andTlr4/mice. Splenocytes from infected animals were harvested on days 0, 7, and
14 postinfection and stainedwith the indicated antibodies for each subset, as described inMaterials andMethods. The results represent two to three independent
experiments. (B) Spleen size was measured in WT, Tlr4/, and Tlr2/ mice at 7 days postinfection with M. abscessus R. (C and E) Population of memory/
effector CD4 CD44high CD62Llow T cells. (D and F) Population of memory/effector CD8 CD44high CD62Llow T cells. Splenocytes from WT, Tlr2/, and
Tlr4/micewere harvested at the indicated time points, andCD4/CD44/CD62L (C) andCD8/CD44/CD62L (D) cells were stained as described inMaterials and
Methods. The bar graphs in panels E and F represent the percentages of cells in each quadrant. The results are presented as the means standard deviations of
each group (*, P 0.05; **, P 0.01; ***, P 0.001).
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determined by analyzing CD62L and CD44. CD62Llow/CD44high
(effector and central memory) CD4 and CD8 T cells increased
over time in WT and Tlr4/ mice; however, more naive T cells
were detected in Tlr2/mice (Fig. 3C to F). IFN--producing T
cells are essential for the control ofM. abscessus infections inmice.
To assess how the lack of TLR2 affected the development of this
cell population, wemeasured the IFN- production capacity of all
spleen cells obtained from infected animals following stimulation
withM. abscessus R CFA. The secretion of IFN- also increased in
WT and Tlr4/mice; however, the IFN- level was significantly
lower in Tlr2/ mice despite treatment with CFA (see Fig. S6A
and B in the supplemental material).
TLR2 plays a key role in DC activation byM. abscessusR and
in T-cell proliferation. The data above show that TLR2 plays an
important role in the impairment of T-cell expansion and activa-
tion inM. abscessusR infection. Therefore, TLR2 serves to link the
innate and adaptive immune responses in the regulation of M.
abscessus infections. To test this hypothesis, the effects of TLR2 on
the activation of DCs and on antigen presentation by DCs were
investigated. First, BM-DCs were differentiated from WT,
Tlr2/, and Tlr4/mice using GM-CSF/IL-4. To test the ability
ofM. abscessus to activate BM-DCs via TLR2, we treated BM-DCs
with M. abscessus CFA or performed direct infection with M. ab-
scessus andmeasured the expression of surfacemolecules and pro-
inflammatory cytokines. As shown in Fig. 4A and B, surface mol-
ecule expression and proinflammatory cytokine secretion were
enhanced in WT and Tlr4/ BM-DCs following treatment with
M. abscessus CFA or direct infection with M. abscessus but were
strongly diminished in Tlr2/ BM-DCs. To verify the effects of
TLR2 on T-cell proliferation, we performed a syngeneic MLR as-
say usingOT-I T-cell receptor (TCR) transgenic CD8T cells and
OT-II TCR transgenic CD4 T cells. Transgenic CFSE-labeled
OVA-specific CD4 and CD8 T cells were cocultured with M.
abscessus CFA-treated BM-DCs isolated from WT, Tlr2/, and
Tlr4/ mice. The results showed that BM-DCs from WT and
Tlr4/ mice induced significantly greater CD4 and CD8 T-
cell proliferation than Tlr2/ BM-DCs pulsed with M. abscessus
CFA (Fig. 5A and B). In addition, syngeneic CD4 and CD8 T
cells primedwithM.abscessusCFA-treatedBM-DCs isolated from
WT and Tlr4/ mice produced significantly (P 0.001) higher
levels of IFN- and IL-2 than those primed withTlr2/ BM-DCs
(Fig. 5C and D); however, the differences in IL-4 secretion levels
between BM-DCs from WT, Tlr2/, and Tlr4/ mice were
barely detectable. These results support the hypothesis that TLR2
plays a key role in T-cell proliferation through the presentation of
M. abscessus antigens and the conversion from innate to adaptive
immunity.
Therapeutic intervention via activated dendritic cells. An
analysis of the Tlr2/mice infected withM. abscessus R suggests
that TLR2 is part of an effective immune response and that TLR2
plays a key role in DCs in the conversion from innate immunity to
adaptive immunity againstM. abscessus R. To test this hypothesis,
we transferred M. abscessus CFA-treated mature BM-DCs from
WTmice to Tlr2/mice infected withM. abscessus R. Unstimu-
lated immature BM-DCs from WT mice were injected into
Tlr2/mice as a control, and the survival rates and bacterial CFU
counts were monitored for 30 days (Fig. 6A). While allM. absces-
sus R-infected Tlr2/ mice died within 25 days of infection, the
recipient mice were almost completely protected against M. ab-
scessus R (Fig. 6B). In addition, bacterial CFU counts in the lungs
were significantly reduced in the Tlr2/ mice receiving mature
BM-DCs (Fig. 6C). We further investigated the effect of CFA-
treated mature BM-DCs from WT mice on the recruitment of
inflammatory cells. As shown in Fig. 6D, the recruitment of
monocytes, DCs, CD11bmid DCs, CD11bhigh macrophages, neu-
trophils, and CD4 T and CD8 T lymphocytes into the bron-
choalveolar space was markedly increased in the recipient mice
compared with levels in Tlr2/mice at 7 days postinfection. The
recipient mice also showed significantly increased cytokine re-
sponses, which reached levels comparable to those observed in
Tlr2/mice (Fig. 6E). Finally, to determinewhetherCFA-treated
mature BM-DCs could enhance adaptive immunity in Tlr2/
mice, we isolated splenocytes from each group of mice and ana-
lyzed the changes in spleen size, CD4T cells, and theCD8 effector/
memory T lymphocyte ratio. As shown in Fig. 6F, the spleens were
substantially larger in the recipient mice than in Tlr2/ mice at
day 7. Levels of CD62Llow/CD44high (effector and central mem-
ory) CD4 and CD8 T cells were markedly increased in the re-
cipient mice compared with those in Tlr2/ mice (Fig. 6G).
These results strongly suggest that TLR2 fromDCs plays a key role
in the conversion from innate immunity to adaptive immunity
during infection withM. abscessus R. DC therapy is likely to be an
excellent approach for the treatment of M. abscessus.
DISCUSSION
In this study, we investigated the functional role of TLR2 in the
generation of early protective immunity against M. abscessus. We
found that TLR2 contributes to the initiation of Th1-type T-cell
immunity rather than to the innate killing of mycobacteria. Mac-
rophage infectionwith anM. abscessus S or R variant did not differ
among WT, Tlr2/, and Tlr4/ mice in terms of intracellular
CFU counts (see Fig. S4 in the supplemental material). Neverthe-
less, the recognition of M. abscessus R variants by TLR2 is crucial
for the production of TNF- and IL-12p70 from both macro-
phages and DCs. Interestingly, TLR2 did not affect cytokine pro-
duction in response to M. abscessus S. This result was consistent
with a previous study showing that GPL in the outermost layer of
the M. abscessus cell wall masks the role of underlying cell wall
lipids that are involved in stimulating the innate immune response
through TLR2 (23). In addition, our results suggest that a partic-
ular mycobacterial morphotype is associated with a specific dis-
ease phenotype and that the effective control of this morphotype
requires a more efficient immune response (23, 24).
Most innate immune cells such as neutrophils and macro-
phages are rapidly recruited to the site of a mycobacterial infec-
tion, where they recognize the pathogens and initiate and regulate
immune responses. The ability of phagocytes to kill mycobacteria
in vivomost likely depends on the tissuemicroenvironment, stage
of infection, individual host, and infecting organism. The interac-
tion of phagocytes with other cells and the downstream effects on
T-cell activity could result in a range of outcomes, from early
clearance of infection to the dissemination of viable bacteria and
an attenuated acquired immune response. In Tlr2/ mice with
established disease, neutrophils, monocytes, DCs, and macro-
phages accumulate under conditions of high pathogen load or
immunological dysfunction in the later stages of infection. These
cells are likely to contribute to pathology.
The development and progression ofM. abscessus-related lung
disease may depend on the balance between bacterial virulence
andhost defense.Mycobacterial virulence andhost predisposition
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influence the progression of lung disease mediated by nontuber-
culous mycobacteria, including M. abscessus. Nevertheless, many
reports have revealed that rough variants tend to bemore virulent
in experimental infections. Previous studies have suggested that
the hyperlethality of rough M. abscessus strains may be related to
mediators of the host innate response via TNF- (23). In addition,
overproduction of TNF- may directly participate in immuno-
pathological reactions or reflect a dysregulated immune response;
FIG 4 Maturation of bone marrow-derived dendritic cells (BM-DCs) via the direct engagement of TLR2 in response to M. abscessus R or its culture filtrate
antigen. (A) A representative dot plot of dendritic cells derived fromWT,Tlr2/, andTlr4/mice primarily gated on FSC and SSC (R1) and secondarily gated
(R2) according to the expression of CD11c. Histograms for CD80, CD86,MHC-I, andMHC-II expression byM. abscessusR-infected (MOI of 1) orM. abscessus
culture filtrate antigen (10 g/ml)-treated CD11c-gated DCs derived fromWT, Tlr2/, and Tlr4/mice. The percentage of positive cells is shown for each
panel. Bar graphs show themeans SEMof the percentages for each surfacemolecule on CD11c cells in three independent experiments. (B) DCs derived from
WT, Tlr2/, and Tlr4/mice were treated or infected as described in panel A. TNF- and IL-1	 production in DCs derived fromWT, Tlr2/, and Tlr4/
mice was measured by ELISA in response toM. abscessus R or its culture filtrate. All data are expressed as the means SEM (n 3), and statistical significance
(***, P 0.001) is shown for BM-DCs from Tlr2/ DCs compared to those from WT and Tlr4/ DCs.
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however, the production of TNF- in response to mycobacterial
infection orchestrates the early induction of chemokines and is
required for the coordination of leukocytes recruited into granu-
lomas (25). It is obvious that TLR2 contributes to the host defense
mechanisms that control M. abscessus infection for several rea-
sons. First, Tlr2/ mice were extremely susceptible to infection
by the M. abscessus rough strain. Second, Tlr2/ mice infected
with M. abscessus rough strains displayed uncontrolled bacterial
burdens. Finally, the reconstitution of TLR2 WT DCs enabled
Tlr2/mice to control infection by a hypervirulent rough mor-
photype ofM.abscessus. Thus, TLR2-mediated immune responses
are protective rather than pathological host responses.
The uncontrolled infection in Tlr2/mice resulted from the
noninduction of immune effectors. First, Tlr2/ mice systemi-
cally and locally failed to produce crucial cytokines (IFN-,
TNF-, and IL-12p70) to generate Th1-polarized immunity. Im-
paired TLR2 expression resulted in decreased IL-12 and TNF-
production in NTM lung disease, which contributed to host sus-
ceptibility (26, 27). In addition, researchers using the same M.
abscessus infectionmodel (IFN- receptor-1 KOmice and TNF-
KOmice) found that mice with either genetic disruption had sig-
nificantly more M. abscessus bacteria in their livers and spleens
thanWTmice (11, 13). TNF- and IFN- were thus shown to be
essential in the host defense againstM. abscessus in mice. Second,
FIG 5 Proliferation and polarization of naive CD4 and CD8 T cells after coculture with M. abscessus R CFA-treated mouse BM-DCs generated from WT,
Tlr2/, and Tlr4/mice. Transgenic OVA-specific CD4 T cells and transgenic OVA-specific CD8 T cells were isolated, stained with CFSE, and cocultured
for 96 h with DCs treated withM. abscessusCFA (10g/ml). OVA-specific CD4 T cells were then pulsed with an OVA peptide consisting of residues 323 to 339
(OVA323–339; 1g/ml) (A), and OVA-specific CD8
 T cells were pulsed with OVA257–264 (1g/ml) (B). T cells alone and T cells cocultured with untreated DCs
served as controls. The proliferation of OT-II (A) and OT-I (B) T cells was then assessed by flow cytometry. (C) The culture supernatants obtained from the
conditions described in panel A were harvested after 24 h, and IFN-, IL-2, and IL-4 weremeasured by ELISA. Themean SEM is shown for three independent
experiments (***,P 0.001). (D) The culture supernatants obtained from the conditions described in panel Bwere harvested after 24 h, and IFN- and IL-2were
measured by ELISA. The mean SEM is shown for three independent experiments (***, P 0.001).
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early recruitment of neutrophils, macrophages, and DCs into the
lungs failed in Tlr2/mice infected with the M. abscessus rough
variant. Interestingly, in a murine model of infection with Myco-
bacterium fortuitum, which is similar to M. abscessus, the early
neutrophilic response was an important contributor to infection
control (28). Although increased neutrophilic infiltration in the
lungs was observed in leptin-deficient ob/ob mice, which were
more susceptible to infection with aerosolized M. abscessus (11),
whether neutrophils were important in the host defense or the
pathogenesis of M. abscessus lung infection was not specifically
addressed; however, the delayed influx of neutrophils, macro-
phages, and DCs into the lungs of Tlr2/ mice clearly indicates
that these immune cells are more likely related to host defense.
Notably, immune cells involved in the innate immune response
FIG 6 Immunotherapeutic intervention using M. abscessus CFA-treated BM-DCs from WT mice on Tlr2/mice. (A) Schematic diagram of the experiment.
(B and C) WT and Tlr2/ mice were infected i.v. with 1.4  107 CFU/mouse (n  30 animals per group), and the M. abscessus culture filtrate antigen
(CFA)-treated DCs (1.0 106) were injected via the tail vein on day 1 postinfection. Mouse survival and CFU counts were monitored for 30 days postinfection.
The results are expressed as the mean estimated numbers of CFU SEM from the lung samples of five to six mice in two independent experiments (***, P
0.001). iDCs, immature dendritic cells; mDCs, CFA-treated DCs. (D) The bar graph represents the absolute number of cells in the quadrants or squares on day
7 of the initial infection. The results are presented as the means standard deviations of each group (*, P 0.05; **, P 0.01; ***, P 0.001). (E) Comparison
of cytokine production in bronchoalveolar lavage fluid. Bronchoalveolar lavage fluid from infected animals was harvested at day 7 postinfection, and IFN- and
TNF- levels were determined by ELISA. The results are expressed as the means SEM of measurements from five to six animals, and statistical significance is
indicated (*, P 0.05). (F andG)Measurement of spleen size and analysis of memory/effector CD4CD44high CD62Llow and CD8CD44high CD62Llow T cells.
The bar graph represents the percentages of cells in the quadrants. The results are presented as themeans standard deviations of each group (**, P 0.01; ***,
P 0.001).
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may not be directly involved in regulating bacterial infections as
no differenceswere noted in bacterial counts amongWT,Tlr2/,
and Tlr4/ mice by day 7. Rather, the cells that regulate innate
immune responses may suppress early bacterial dissemination
and help to stimulate the adaptive immune response. BecauseM.
abscessus growth is inhibited when the adaptive immune response
is activated, cells responsible for adaptive immunity play a major
role in the regulation of M. abscessus infection. In the absence of
TLR2, the conversion from the innate to the adaptive immune
response was inhibited, potentially leading to a failure to regulate
M. abscessus infection. Additionally, the rapid influx of CD4 and
CD8 T cells into the lungs failed in Tlr2/ mice infected with
theM. abscessus rough variant, indicating that T cells are likely an
essential component of the protective immune response against
M. abscessus. Both the number and functionality of T cells are
crucial for protective immunity against mycobacterial infections.
For example, the increased susceptibility to disseminated M. tu-
berculosis inmice with genetic disruption of IFN- or CD4 dem-
onstrates the importance of these host immune components in
pulmonary tuberculosis (29). Our data show that fewer splenic
CD4 and CD8 cells were detected in Tlr2/mice than in WT
and Tlr4/ mice. Lastly, the expansion of memory/effector
CD4/CD8 CD44high CD62Llow T cells failed in Tlr2/ mice
infected with the M. abscessus rough variant. A population of
CD44high CD62Llow CD4/CD8 effectors was specifically gener-
ated from splenic T cells ofM. abscessus-infectedmice in response
to CFA-treated DCs, indicating that TLR2 generates effector/
memory T cells against M. abscessus infection. Protection against
mycobacterial infection depends upon the rapid generation of ef-
fector memory T cells capable of producing IFN- (30). Thus, we
concluded that the absence of TLR2 signaling in M. abscessus-
infected DCs leads to the failure to initiate T-cell immune
responses. Less IFN- is thus released, resulting in a failure to
activate mycobacterium-containing macrophages to kill myco-
bacteria.
Notably, systemic administration of CFA-treated syngeneic
DCs fromWTmice ex vivo greatly strengthened immune priming
in vivo, inducing a dramatic reduction in bacterial CFU and en-
hancing long-term survival in Tlr2/ mice infected with the
hypervirulent M. abscessus rough variant. Our findings highlight
the essential contribution of TLR2 to protective Th1-type immu-
nity during M. abscessus infection in a morphotype-dependent
manner. Importantly, injecting DCs into WT mice did not accel-
erate the generation of protective immunity against a rough vari-
ant ofM.abscessus in terms of bacterial CFUcounts as normal host
defense mechanisms were sufficient to prevent infection. Thus,
activated DCs are not necessary for controlling mycobacteria
because host immune responses can adequately containmycobac-
terial infection in WT mice. Alternative immunotherapeutics us-
ing activated DCs may therefore be warranted for M. abscessus
treatment if TLR2 variants are detected. The high therapeutic re-
sponse rates attained with M. abscessus-targeted Th1-type T-cell
immunity as a result of CFA-stimulated DCs in a model of severe
infection suggest that the effectiveness and specificity of DCs can
be harnessed to treat M. abscessus. Immunotherapy may be of
clinical importance in the development of new treatments and
targeted interventions for difficult to treat pathogens. Thus, opti-
mal conditions for generating potent immunostimulatory DCs
that overcome antibiotic resistance and immune suppression are
key factors inDC-basedM.abscessus immunotherapy.DC-depen-
dent aspects of the optimal immune response contribute to resolv-
ing infections and could also represent a compensatory host
mechanism in the face of uncontrolled bacterial replication. The
ideas presented in this studymight ultimately be of importance for
patients. Their early defensive function and potential contribu-
tion to disease progression may make DCs especially significant.
In conclusion, this study provides essential evidence that TLR2
plays a crucial role in the initiation of protective immune re-
sponses against a rough morphotype ofM. abscessus by activating
innate immune cells and polarizing the development of T cells to
generate a Th1 response. The development of specific agents that
compensate for the TLR2 signaling pathway may be useful in the
design of new strategies to prevent chronic diseases caused by
rough morphotypes of M. abscessus. The successful use of DC
immunotherapy in the treatment of M. abscessus will open ave-
nues for the development of new immunotherapeutic strategies
and better clinical outcomes.
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